May 2013

Questions have arisen regarding the standards for determining whether a generic medication is bioequivalent to the branded version.

This monoclonal antibody is approved to treat atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria.

Two new medications have recently been approved to help patients lose weight: lorcaserin and phentermine and topiramate extended-release.

The approval of ipilimumab and vemurafenib in 2011 marked a significant advance in the treatment of melanoma, and a number of new investigational agents are in the pipeline.